Squadron Capital Llc Sells 326,700 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) major shareholder Squadron Capital Llc sold 326,700 shares of the firm’s stock in a transaction on Friday, August 28th. The shares were sold at an average price of $23.04, for a total value of $7,527,168.00. Following the completion of the sale, the insider directly owned 6,536,764 shares of the company’s stock, valued at approximately $150,607,042.56. This trade represents a 4.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Squadron Capital Llc also recently made the following trade(s):

• On Tuesday, September 1st, Squadron Capital Llc sold 10,131 shares of OrthoPediatrics stock. The stock was sold at an average price of $23.10, for a total transaction of $234,026.10.
• On Wednesday, August 26th, Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.28, for a total transaction of $437,040.00.
• On Tuesday, August 25th, Squadron Capital Llc sold 16,300 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.74, for a total value of $403,262.00.
• On Monday, August 24th, Squadron Capital Llc sold 4,000 shares of OrthoPediatrics stock. The stock was sold at an average price of $25.75, for a total transaction of $103,000.00.

OrthoPediatrics Stock Down 1.3%

Shares of NASDAQ KIDS traded down $0.31 during midday trading on Tuesday, reaching $23.00. 139,797 shares of the company’s stock were exchanged, compared to its average volume of 281,544. The stock has a market capitalization of $600.53 million, a PE ratio of -13.69 and a beta of 0.99. OrthoPediatrics Corp. has a 52-week low of $14.42 and a 52-week high of $26.74. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.17 and a current ratio of 4.78. The business’s fifty day moving average price is $21.61 and its two-hundred day moving average price is $18.76.

OrthoPediatrics (NASDAQ:KIDS) last released its earnings results on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The company had revenue of $70.51 million during the quarter, compared to analysts’ expectations of $68.21 million. Analysts forecast that OrthoPediatrics Corp. will post -1.14 EPS for the current year.

Trending Headlines about OrthoPediatrics

Here are the key news stories impacting OrthoPediatrics this week:

• Positive Sentiment: Analysts assigned OrthoPediatrics a consensus price target of $26.44, implying potential upside from recent trading levels and signaling continued confidence in the company’s long-term growth prospects. OrthoPediatrics Receives $26.44 Consensus Price Target
• Neutral Sentiment: The reported sales appear across related director, major-shareholder and beneficial-ownership filings, meaning some transactions may represent overlapping disclosures rather than entirely separate blocks of stock. After the transactions, the reporting holders still controlled approximately 6.53 million shares, indicating continued substantial exposure to KIDS. SEC Insider Transaction Filing
• Negative Sentiment: Director David R. Pelizzon and major shareholder Jennifer N. Pritzker reported sales of 326,700 shares on August 28 at an average price of $23.04, worth approximately $7.53 million. Each reduced their reported ownership by 4.76%, which may pressure the stock or raise concerns about insider confidence, although both retained large positions. SEC Major Shareholder Ownership Filing
• Negative Sentiment: The same holders, along with Squadron Capital LLC, reported additional sales of 10,131 shares on September 1 at $23.10, worth approximately $234,000 per reported transaction. The small 0.15% ownership reduction is less significant by itself, but reinforces the near-term insider-selling overhang. SEC Ownership Filing

Wall Street Analyst Weigh In

Several brokerages recently commented on KIDS. Piper Sandler reissued an “overweight” rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. Weiss Ratings upgraded shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. BTIG Research lifted their price objective on shares of OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, August 20th. Needham & Company LLC increased their target price on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Finally, TD Cowen reissued a “buy” rating on shares of OrthoPediatrics in a research report on Monday, June 15th. Nine equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $26.44.

Hedge Funds Weigh In On OrthoPediatrics

Several large investors have recently bought and sold shares of the stock. BlackRock Inc. bought a new position in shares of OrthoPediatrics during the 2nd quarter worth about $24,347,000. Millennium Management LLC increased its stake in OrthoPediatrics by 48.0% during the fourth quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock valued at $24,802,000 after acquiring an additional 452,840 shares during the period. AIGH Capital Management LLC acquired a new position in OrthoPediatrics in the 2nd quarter valued at approximately $5,161,000. Nantahala Capital Management LLC acquired a new stake in shares of OrthoPediatrics during the 2nd quarter worth approximately $4,636,002. Finally, AWM Investment Company Inc. bought a new stake in shares of OrthoPediatrics during the second quarter valued at approximately $4,537,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.